{"id":708816,"date":"2024-08-05T15:40:02","date_gmt":"2024-08-05T15:40:02","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=708816"},"modified":"2024-08-05T15:40:02","modified_gmt":"2024-08-05T15:40:02","slug":"the-us-dialysis-services-market-to-hit-2348-billion-by-2029-chronic-kidney-diseases-segment-to-witness-the-fastest-growth-rate-arizton","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/the-us-dialysis-services-market-to-hit-2348-billion-by-2029-chronic-kidney-diseases-segment-to-witness-the-fastest-growth-rate-arizton_708816.html","title":{"rendered":"The US Dialysis Services Market to Hit $23.48 Billion by 2029 – Chronic Kidney Diseases Segment to Witness the Fastest Growth Rate – Arizton"},"content":{"rendered":"
\n
\"The<\/a><\/div>\n
\n
U.S. Dialysis Services Market Research Report by Arizton<\/div>\n<\/div>\n<\/div>\n

\u202fAccording to Arizton’s latest research report, the US dialysis services market<\/a> is growing at a CAGR of 1.29% during 2023-2029. <\/p>\n

 <\/p>\n

To Know More, Click: https:\/\/www.arizton.com\/market-reports\/us-dialysis-services-market<\/a> <\/strong>\u202f\u202f\u202f\u202f <\/p>\n

 <\/p>\n

Report Summary\u202f\u202f\u202f\u202f\u202f\u202f\u202f <\/strong><\/p>\n

Market Size (2029):<\/strong> $23.48 Billion\u202f\u202f\u202f <\/p>\n

Market Size (2023):<\/strong> $21.74 Billion\u202f\u202f <\/p>\n

CAGR (2023-2029):<\/strong> 1.29%\u202f\u202f <\/p>\n

Historic Year:<\/strong> 2020-2022\u202f\u202f <\/p>\n

Base Year:<\/strong> 2023\u202f\u202f <\/p>\n

Forecast Year:<\/strong> 2024-2029\u202f\u202f <\/p>\n

Market Segmentation:<\/strong> Service, End-User, Age Group, Disease Type <\/p>\n

 <\/p>\n

Stay ahead of the curve with Arizton’s exclusive subscription plan, offering in-depth analysis, market sizing, and growth forecasts for less than $900 per month—a significant value compared to individual report purchases. Click here: https:\/\/www.arizton.com\/subscription<\/a>\u202f\u202f\u202f\u202f\u202f\u202f\u202f\u202f\u202f\u202f\u202f\u202f\u202f <\/strong><\/p>\n

\u202f\u202f\u202f\u202f\u202f\u202f <\/p>\n

The US dialysis service market is fiercely competitive, driven by domestic, regional, and international players. The market’s competitiveness is further heightened by key players’ extensive geographical presence and distribution networks, which enhance their dialysis service delivery strategies. The COVID-19 pandemic notably escalated the demand for home dialysis services, intensifying competition among market participants. <\/p>\n

Leading players in the dialysis service market include B. Braun Melsungen, DaVita, Dialysis Clinic (DCI), Fresenius Medical Care, and Innovative Renal Care. During the pandemic, these companies expanded their dialysis delivery networks through in-center, home, and hospital dialysis services, which helped them build a robust customer base and achieve significant revenue growth. <\/p>\n

According to DaVita, the dialysis service industry has remained highly competitive for the past two decades. Both large and medium-sized providers are experiencing intense competition. Companies like DaVita and Fresenius Medical Care face substantial competition from various regional and local players on a global scale. <\/p>\n

 <\/p>\n

Chronic Kidney Diseases is the Fastest Growing Segment With A CAGR Of 1.38%  <\/strong><\/p>\n

The chronic kidney disease (CKD) segment is the dominant force in the market. This segment is anticipated to see absolute growth and incremental revenue increase, driven by the rising burden of CKD, which is expected to boost the demand for dialysis services in the US. <\/p>\n

Chronic kidney disease, also known as chronic renal disease or chronic kidney failure, remains a major public health issue. The escalating prevalence of CKD contributes to the high cost of adequate care in the US. End-stage kidney disease (ESKD) is notably prevalent in North and Latin America, with significant rates also found in some European countries and Australia. In the US, the prevalence of CKD is approximately 14%, affecting around 35.5 million individuals. <\/p>\n

By 2040, CKD is projected to be among the top five leading causes of death, highlighting substantial growth opportunities for the dialysis service market. The COVID-19 pandemic has exacerbated both CKD and ESKD conditions, further increasing the demand for dialysis services. Ongoing initiatives to improve kidney health and dialysis access for CKD patients are expected to drive market growth. <\/p>\n

 <\/p>\n

Buy this Research @ https:\/\/www.arizton.com\/market-reports\/us-dialysis-services-market<\/a> <\/strong><\/p>\n

 <\/p>\n

Key Vendors <\/strong><\/p>\n